Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six months later one stays healthy while the other contracts the virus. A new study published in Science Translational Medicine could help explain this difference. Researchers tracked individuals’ antibody levels after vaccinations and identified four distinct patterns of immune response after the first booster vaccination. Notably, the group that started with the highest antibody levels but experienced a faster decline were infected earlier. People with lower blood levels of IgA(S) antibodies, which protect the nose and throat, were also at higher risk. The findings suggest that monitoring how antibody levels change over time could assist in identifying individuals at greater risk of infection.

A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, shows that remote perioperative monitoring (RPM) significantly improves recovery for cancer surgery patients.

Morin-based powder, extracted from guava leaves, apple peel, and figs, can be slowly released with the help of polymers and serve as an alternative to antibiotics. A platform developed at FOAr-UNESP processes morin to obtain it in the form of a fine powder, similar to powdered milk. The final product is intended for use by people with reduced motor skills, such as older adults and patients with special needs, who are unable to brush their teeth properly.

A University of Houston researcher found that recording brain activity while a person listens to a story may help diagnose primary progressive aphasia, a rare neurodegenerative syndrome that impairs language skills.